Literature DB >> 35119145

Analysis of chromatin accessibility in p53 deficient spermatogonial stem cells for high frequency transformation into pluripotent state.

Sitong Liu1, Rui Wei2, Hongyang Liu2, Ruiqi Liu3, Pengxiao Li3, Xiaoyu Zhang2, Wei Wei4, Xiaodong Zhao3, Xiaomeng Li4, Yang Yang5, Xueqi Fu1, Kang Zou2.   

Abstract

OBJECTIVES: Spermatogonial stem cells (SSCs), the germline stem cells (GSCs) committed to spermatogenesis in niche, can transform into pluripotent state in long-term culture without introduction of exogenous factors, typically in p53 deficiency condition. As the guardian for genomic stability, p53 is associated with epigenetic alterations during SSCs transformation. However, the mechanism is still unknown, since complicated roles of p53 baffle our understanding of the regulating process.
MATERIALS AND METHODS: The chromatin accessibility and differentially expressed genes (DEGs) were analysed in p53+/+ and p53-/- SSCs using the Assay for Transposase-Accessible Chromatin with high-throughput Sequencing (ATAC-seq) and RNA-sequencing (RNA-seq), to explore the connection of p53 and cell fate at chromosomal level.
RESULTS: Several transcription factors (TFs), such as CTCF, SMAD3 and SOX2, were predicted as important factors mediating the transformation. Molecular evidence suggested that SMAD3 efficiently promoted pluripotency-associated gene expression both in fresh and long-term cultured SSCs. However, p53 knockout (KO) is insufficient to induce SMAD3 expression in SSCs.
CONCLUSIONS: These observations indicate that SMAD3 is a key factor for SSCs transformation, and an unknown event is required to activate SMAD3 as the prerequisite for SSCs reprogramming, which may occur in the long-term culture of SSCs. This study demonstrates the connection of p53 and pluripotency-associated factors, providing new insight for understanding the mechanisms of SSCs reprogramming and germline tumorigenesis.
© 2022 The Authors. Cell Proliferation published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ATAC-seq; chromatin accessibility; embryonic stem-like; germline; transcription factor

Mesh:

Substances:

Year:  2022        PMID: 35119145      PMCID: PMC8891552          DOI: 10.1111/cpr.13195

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  59 in total

1.  Derivation of novel human ground state naive pluripotent stem cells.

Authors:  Ohad Gafni; Leehee Weinberger; Abed AlFatah Mansour; Yair S Manor; Elad Chomsky; Dalit Ben-Yosef; Yael Kalma; Sergey Viukov; Itay Maza; Asaf Zviran; Yoach Rais; Zohar Shipony; Zohar Mukamel; Vladislav Krupalnik; Mirie Zerbib; Shay Geula; Inbal Caspi; Dan Schneir; Tamar Shwartz; Shlomit Gilad; Daniela Amann-Zalcenstein; Sima Benjamin; Ido Amit; Amos Tanay; Rada Massarwa; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

2.  Culture of mouse spermatogonial stem cells.

Authors:  M Nagano; M R Avarbock; E B Leonida; C J Brinster; R L Brinster
Journal:  Tissue Cell       Date:  1998-08       Impact factor: 2.466

3.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

Authors:  Sven Heinz; Christopher Benner; Nathanael Spann; Eric Bertolino; Yin C Lin; Peter Laslo; Jason X Cheng; Cornelis Murre; Harinder Singh; Christopher K Glass
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

4.  Generation of pluripotent stem cells from neonatal mouse testis.

Authors:  Mito Kanatsu-Shinohara; Kimiko Inoue; Jiyoung Lee; Momoko Yoshimoto; Narumi Ogonuki; Hiromi Miki; Shiro Baba; Takeo Kato; Yasuhiro Kazuki; Shinya Toyokuni; Megumi Toyoshima; Ohtsura Niwa; Mitsuo Oshimura; Toshio Heike; Tatsutoshi Nakahata; Fumitoshi Ishino; Atsuo Ogura; Takashi Shinohara
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

Review 5.  Genetic control of susceptibility to spontaneous testicular germ cell tumors in mice.

Authors:  Man-Yee Josephine Lam; Joseph H Nadeau
Journal:  APMIS       Date:  2003-01       Impact factor: 3.205

6.  The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.

Authors:  Ajoy Aloysius; Ramanuj DasGupta; Jyotsna Dhawan
Journal:  Sci Signal       Date:  2018-07-24       Impact factor: 8.192

7.  Analysis of chromatin accessibility in p53 deficient spermatogonial stem cells for high frequency transformation into pluripotent state.

Authors:  Sitong Liu; Rui Wei; Hongyang Liu; Ruiqi Liu; Pengxiao Li; Xiaoyu Zhang; Wei Wei; Xiaodong Zhao; Xiaomeng Li; Yang Yang; Xueqi Fu; Kang Zou
Journal:  Cell Prolif       Date:  2022-02-04       Impact factor: 6.831

8.  Transcriptional regulatory networks underlying the reprogramming of spermatogonial stem cells to multipotent stem cells.

Authors:  Hoe-Su Jeong; Jinhyuk Bhin; Hyung Joon Kim; Daehee Hwang; Dong Ryul Lee; Kye-Seong Kim
Journal:  Exp Mol Med       Date:  2017-04-14       Impact factor: 8.718

Review 9.  Is imprinting the result of "friendly fire" by the host defense system?

Authors:  Miroslava Ondičová; Rebecca J Oakey; Colum P Walsh
Journal:  PLoS Genet       Date:  2020-04-09       Impact factor: 5.917

Review 10.  Functions of p53 in pluripotent stem cells.

Authors:  Xuemei Fu; Shouhai Wu; Bo Li; Yang Xu; Jingfeng Liu
Journal:  Protein Cell       Date:  2019-11-06       Impact factor: 14.870

View more
  2 in total

1.  Analysis of chromatin accessibility in p53 deficient spermatogonial stem cells for high frequency transformation into pluripotent state.

Authors:  Sitong Liu; Rui Wei; Hongyang Liu; Ruiqi Liu; Pengxiao Li; Xiaoyu Zhang; Wei Wei; Xiaodong Zhao; Xiaomeng Li; Yang Yang; Xueqi Fu; Kang Zou
Journal:  Cell Prolif       Date:  2022-02-04       Impact factor: 6.831

2.  Regulation of male germline transmission patterns by the Trp53-Cdkn1a pathway.

Authors:  Mito Kanatsu-Shinohara; Honda Naoki; Takashi Tanaka; Misako Tatehana; Takako Kikkawa; Noriko Osumi; Takashi Shinohara
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.